Morgan Stanley’s LAVA Therapeutics LVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.3K | Sell |
|
|||||
|
2025
Q1 | $15K | Buy |
|
|||||
|
2024
Q4 | $8.08K | Sell |
|
|||||
|
2024
Q3 | $60.4K | Buy |
|
|||||
|
2024
Q2 | $28.1K | Buy |
|
|||||
|
2024
Q1 | $34K | Sell |
|
|||||
|
2023
Q4 | $78.4K | Buy |
|
|||||
|
2023
Q3 | $15.1K | Buy |
|
|||||
|
2023
Q2 | $20.7K | Buy |
|
|||||
|
2023
Q1 | $14.8K | Buy |
|
|||||
|
2022
Q4 | $24.5K | Buy |
|
|||||
|
2022
Q3 | $23K | Sell |
|
|||||
|
2022
Q2 | $17K | Buy |
|
|||||
|
2022
Q1 | $12K | Sell |
|
|||||
|
2021
Q4 | $24K | Buy |
|